PKM and hepatocellular carcinoma: Wu et al. analyzed the data of 2812 patients with solid tumors of digestive system obtained from 16 cohort studies and found that overexpression of PKM2 is associated with reduced overall survival in gastric cancer, esophageal squamous cell carcinoma, hepatocellular carcinoma, biliary cancer and oral cancer [82].